臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| Total items :0
	Visitors : 51889039 Online Users : 901 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library

Scope

Adv. Search

Login

Administrator

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"lu y s"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 11-20 of 467 (47 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2022-08-19T00:21:10Z	A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer	Lin C.-C.; Cheng A.-L.; Hsu C.-H.; Lu Y.-S.; CHIUN HSU; Yeh K.-H.; Wu C.-Y.; Huang C.-S.; Yang C.-H.
臺大學術典藏	2022-08-19T00:21:05Z	Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway	Chen K.-F.; Yeh P.-Y.; CHIUN HSU; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:21:05Z	Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma	Cheng A.-L.; CHIUN HSU; Wang D.-S.; Lu Y.-S.; Fan H.-H.; Ou D.-L.; Shen Y.-C.; Liang J.-D.; Liou J.-Y.; Yu S.-L.
臺大學術典藏	2022-08-19T00:21:02Z	Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin	Cheng A.-L.; Lin C.-H.; Chang K.-J.; Kuo W.-H.; CHIUN HSU; Lee W.-C.; Liau J.-Y.; Huang C.-S.; Lu Y.-S.; Shao Y.-Y.; Kuo K.-T.; Hu F.-C.
臺大學術典藏	2022-08-19T00:20:59Z	Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era	Lu Y.S.; Cheng A.L.; Kuo W.H.; Chen I.C.; Lin C.H.; Huang C.S.; Lien H.C.; CHIUN HSU
臺大學術典藏	2022-08-19T00:20:58Z	Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma	Shao Y.-Y.; Lin Z.-Z.; CHIUN HSU; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:20:55Z	Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy	Shau W.-Y.; Chen T.-J.; Yang S.-H.; Huang S.-M.; CHIUN HSU; Lu Y.-S.; Cheng A.-L.; Lin C.-H.; Kuo Y.-H.
臺大學術典藏	2022-08-19T00:20:54Z	The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines	Cheng A.-L.; Lu Y.-S.; Chen W.-W.; Chang D.-Y.; Huang S.-M.; Lin C.-H.; CHIUN HSU; Lin M.-H.; Huang C.-S.
臺大學術典藏	2022-08-12T06:28:23Z	Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma	Hsu C.; Huang C.-S.; Chao T.-Y.; Lu Y.-S.; Bu C.-F.; Chen M.M.; KING-JEN CHANG; Cheng A.-L.
臺大學術典藏	2022-08-12T06:28:15Z	Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms	Lien H.-C.; Lu Y.-S.; Cheng A.-L.; Chang W.-C.; Jeng Y.-M.; Kuo Y.-H.; Huang C.-S.; KING-JEN CHANG; Yao Y.-T.

Showing items 11-20 of 467 (47 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page